Investor Presentaiton

There is significant untapped potential in the laryngectomy market today, which we will seek to eliminate The laryngectomy market, DKKbn Low level of market penetration due to: We will eliminate the 'white space' by: -10% CAGR (2015-20) White space (global market potential) 01 Lack of clinical standards in existing markets outside of Northern Europe 02 Patients are not compliant in their use Penetrated 1.0-1.5 markets Today Future 03 Market Lack of reimbursement in most of emerging markets -85% share 55 Setting the clinical standards and increasing penetration in existing markets, such as the US Increasing compliance in existing markets Opening and developing new markets, such as Brazil, South Korea and China Coloplast

View entire presentation